Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19

CompletedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Severe Acute Respiratory SyndromeVentilation Pneumonitis
Interventions
DRUG

Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets

24 mg oral Ivermectin on days 0 and 7 and 1 Aspirin tablet daily for 30 days. Outpatient treatment.

OTHER

Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets

36 mg oral Ivermectin on days 0 and 7; 1 daily injection of 4-mg Dexamethasone until discharge, 1 Aspirin tablet daily for 30 days. Inpatient treatment in ward care, including Low flow washed oxygen or oxygen concentrator

OTHER

Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.

48 mg oral Ivermectin on days 0 and 7; 1 daily injection of 4-mg Dexamethasone until discharge, Enoxaparin 100 IU/kg (ca. 1 mg/kg) daily until transfer to ward care. Then continue with inpatient treatment in ward care.

Trial Locations (1)

1802

Hospital Eurnekian, Buenos Aires

All Listed Sponsors
lead

Eurnekian Public Hospital

OTHER

NCT04425863 - Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 | Biotech Hunter | Biotech Hunter